1B-LSD: 1B-LSD is an N1-acylated prodrug that is rapidly hydrolyzed in vitro and in vivo to LSD via CYP1A2 and CYP3A4 enzymes. Animal studies show approximately 14% the potency of LSD by weight; blotters marketed at 100 ug 1B-LSD produce subjective effects comparable to 75-100 ug LSD in many users.
Related pages